(Q35226646)

7 August 2017

1 reference

title

Controversies in the nonsurgical treatment of stage III non-small cell lung cancer (English)

1 reference

7 August 2017

Controversies in the Nonsurgical Treatment of Stage III Non-small Cell Lung Cancer (English)

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/145.4_PT_1.967

2 December 2023

author name string

Hazuka MB

1

1 reference

7 August 2017

Bunn PA Jr

2

1 reference

7 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1313216

12 September 2022

publication date

1 April 1992

1 reference

The American Review of Respiratory Disease

7 August 2017

1 reference

7 August 2017

145

1 reference

7 August 2017

4 Pt 1

1 reference

7 August 2017

967-977

1 reference

Treatment of inoperable carcinoma of the bronchus by megavoltage X rays

7 August 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F145.4_PT_1.967

Indications for and resuls of irradiation of carcinoma of the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F145.4_PT_1.967

Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F145.4_PT_1.967

Biologic basis for altered fractionation schemes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F145.4_PT_1.967

Actual growth rate and tumour cell proliferation in human pulmonary neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F145.4_PT_1.967

A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F145.4_PT_1.967

Etoposide versus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer. Results of a prospective randomized FONICAP trial. Italian Lung Cancer Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F145.4_PT_1.967

Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F145.4_PT_1.967

Brief Intensive Chemotherapy for Metastatic Non-Small-Cell Lung Cancer: A Phase II Study of the Weekly CODE Regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F145.4_PT_1.967

Sequencing of drugs and radiation. The integrated alternating regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F145.4_PT_1.967

Five-year results by intensive high voltage therapy of inoperable bronchial carcinoma

21 January 2018

4

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/145.4_PT_1.967

A new international staging system for lung cancer

2 December 2023

7

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/145.4_PT_1.967

Effects of calcium on the growth of the rat conceptus during organogenesis in vitro

2 December 2023

8

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/145.4_PT_1.967

Non-small-cell lung cancer: should unresectable stage III patients routinely receive high-dose radiation therapy?

2 December 2023

10

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/145.4_PT_1.967

The survival of patients with inoperable lung cancer: a large-scale randomized study of radiation therapy versus placebo.

2 December 2023

11

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/145.4_PT_1.967

Radiotherapy employing three fractions in each day over a continuous period of 12 days

2 December 2023

22

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/145.4_PT_1.967

Twice-a-day radiation therapy for cancer of the head and neck

2 December 2023

23

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/145.4_PT_1.967

Fast neutron and mixed beam radiotherapy for inoperable non-small cell carcinoma of the lung. Results of an RTOG randomized study

2 December 2023

25

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/145.4_PT_1.967

Radiotherapy in the management of locally advanced lung cancer of all cell types: final report of randomized trial

2 December 2023

26

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/145.4_PT_1.967

Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small-cell lung cancer

2 December 2023

29

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/145.4_PT_1.967

A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group

2 December 2023

33

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/145.4_PT_1.967

Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma. A randomized study

2 December 2023

46

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/145.4_PT_1.967

Signiicant Effect of Adjuvant Chemotherapy on Survival in Locally Advanced Non-Small-Cell Lung Carcinoma

2 December 2023

48

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/145.4_PT_1.967

2 December 2023

Identifiers

0 references

1 reference